Novo Nordisk Price to Sales Ratio 2006-2020 | NVO

Historical PS ratio values for Novo Nordisk (NVO) over the last 10 years. The current P/S ratio for Novo Nordisk as of July 02, 2020 is .
Novo Nordisk P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2020-07-02 66.36 8.36
2020-03-31 60.20 $7.94 7.58
2019-12-31 57.88 $7.68 7.54
2019-09-30 51.70 $7.28 7.10
2019-06-30 51.04 $7.17 7.12
2019-03-31 52.31 $7.08 7.39
2018-12-31 46.07 $7.04 6.55
2018-09-30 47.14 $7.21 6.54
2018-06-30 45.68 $7.12 6.41
2018-03-31 48.77 $7.02 6.95
2017-12-31 52.28 $6.83 7.65
2017-09-30 46.91 $6.73 6.97
2017-06-30 41.35 $6.66 6.21
2017-03-31 33.05 $6.60 5.01
2016-12-31 33.89 $6.54 5.18
2016-09-30 39.30 $6.49 6.05
2016-06-30 50.33 $6.42 7.84
2016-03-31 50.71 $6.33 8.02
2015-12-31 53.42 $6.21 8.60
2015-09-30 49.88 $6.15 8.11
2015-06-30 50.36 $6.11 8.24
2015-03-31 49.10 $6.07 8.09
2014-12-31 38.34 $6.01 6.38
2014-09-30 43.14 $5.90 7.32
2014-06-30 41.85 $5.74 7.29
2014-03-31 41.36 $5.62 7.36
2013-12-31 32.86 $5.51 5.96
2013-09-30 30.09 $5.37 5.61
2013-06-30 27.56 $5.23 5.27
2013-03-31 28.72 $5.06 5.68
2012-12-31 28.46 $4.88 5.84
2012-09-30 27.52 $4.70 5.86
2012-06-30 25.35 $4.57 5.55
2012-03-31 24.19 $4.42 5.47
2011-12-31 19.75 $4.31 4.59
2011-09-30 17.05 $4.19 4.07
2011-06-30 21.47 $4.10 5.23
2011-03-31 21.46 $3.95 5.43
2010-12-31 19.01 $3.78 5.03
2010-09-30 16.62 $3.62 4.60
2010-06-30 13.68 $3.45 3.97
2010-03-31 13.02 $3.31 3.93
2009-12-31 10.59 $3.21 3.30
2009-09-30 10.44 $3.07 3.41
2009-06-30 9.03 $2.97 3.04
2009-03-31 7.96 $2.66 2.99
2008-12-31 8.34 $2.62 3.18
2008-09-30 8.31 $2.57 3.24
2008-06-30 10.71 $2.44 4.38
2008-03-31 11.23 $1.97 5.71
2007-12-31 10.39 $1.83 5.69
2007-09-30 9.70 $1.78 5.45
2007-06-30 8.70 $1.66 5.24
2007-03-31 7.25 $2.01 3.62
2006-12-31 6.60 $1.91 3.46
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $156.265B $18.296B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.399B 15.88
Roche Holding AG (RHHBY) Switzerland $299.895B 0.00
Novartis AG (NVS) Switzerland $200.421B 15.66
Merck (MRK) United States $198.849B 14.40
Pfizer (PFE) United States $191.697B 11.90
Eli Lilly (LLY) United States $156.734B 25.37
AbbVie (ABBV) United States $146.020B 10.73
AstraZeneca (AZN) United Kingdom $141.191B 29.08
Bristol Myers Squibb (BMY) United States $133.815B 11.18
Sanofi (SNY) $129.264B 14.96
GlaxoSmithKline (GSK) United Kingdom $103.401B 12.34
Bayer (BAYRY) Germany $70.202B 10.01
H Lundbeck (HLUYY) Denmark $7.753B 13.47
Innoviva (INVA) United States $1.417B 8.18